| Name | Leu-AMS |
|---|
| Description | Leu-AMS is a potent inhibitor of leucyl-tRNA synthetase (LRS) with an IC50 of 22.34 nM and inhibits the growth of bacteria. |
|---|---|
| Related Catalog | |
| Target |
IC50: 22.34 nM (LRS)[1] |
| In Vitro | Leu-AMS is proved to be a potent inhibitor of Leucyl-tRNA Synthetase (LRS) with an IC50 value of 22.34 nM. Leu-AMS is highly cytotoxic in both cancer cells and normal cells. Leu-AMS does not affect S6 kinase (S6K) phosphorylation at all. Leu-AMS inhibits the catalytic activity of LRS but does not affect the leucine-induced mTORC1 activation[1]. |
| References |
| Molecular Formula | C16H25N7O7S |
|---|---|
| Molecular Weight | 459.48 |
| Storage condition | 2-8℃ |